Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multi-Center, Open-Label, Parallel-Cohort Study to Characterize Product Use in Smokers Switching From Combustible Cigarettes to a RELX Electronic Nicotine Delivery System (ENDS)

NCT04708106 is registered in ClinicalTrials.gov with Cheerain HK Limited as lead sponsor.

NCT NCT04708106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04708106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multi-Center, Open-Label, Parallel-Cohort Study to Characterize Product Use in Smokers Switching From Combustible Cigarettes to a RELX Electronic Nicotine Delivery System (ENDS)
Lead sponsor
Cheerain HK Limited
Phase
Not applicable
Overall status
Completed
Start date
October 15, 2020
Completion date
July 7, 2021
Enrollment
194 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

electronic cigarette use